(Total Views: 467)
Posted On: 03/12/2020 1:11:26 PM
Post# of 155005
Trding,
Agreed,
FDA is willing to lisen to CYDY. Some doctors telling about patients is more compelling that documents with data, so is a good opportunity.
It will be in the hands of Dr. Patterson and the Oncologists. I hope that the doctor that switched patient #1 to Mono will come and explain the progression of his/her patient and why it believes that there is no need for chemo any more (this is extraordinary imho). Same applies to m-I-l (radiologist explaining why it canceled further radiological treatment) and patients 4 and 5 as well.
And stress that there are no serious adverse events !!!
All together they can present a compelling story to the FDA. This will only further the BTD application.
Agreed,
FDA is willing to lisen to CYDY. Some doctors telling about patients is more compelling that documents with data, so is a good opportunity.
It will be in the hands of Dr. Patterson and the Oncologists. I hope that the doctor that switched patient #1 to Mono will come and explain the progression of his/her patient and why it believes that there is no need for chemo any more (this is extraordinary imho). Same applies to m-I-l (radiologist explaining why it canceled further radiological treatment) and patients 4 and 5 as well.
And stress that there are no serious adverse events !!!
All together they can present a compelling story to the FDA. This will only further the BTD application.
(3)
(0)
